MARSHALL & POPP, LLC

Lobbying for GRAIL, INC. · Biotechnology company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $60,000.00 income · posted Jul 9, 2026

Bills named in this filing 1

Lobbying activity 1

Medicare/Medicaid

Issues related to cancer screening, including the implementation of Section 6221 of H.R.7148 - Consolidated Appropriations Act, 2026, PL 119-75.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.